CD4 and neoplasm: Nevertheless, the infiltration of CD4+ and CD8+ T cells within tumors increased after anlotinib therapy (Fig. 6b, d, e), consistent with a previous report.47 To further evaluate the change in immune response within tumors, we examined the concentrations of various chemokines and cytokines in tumor homogenates.